Farzole CT Capsules is a gastrointestinal formulation combining an acid-suppressing agent with a prokinetic component. It is designed to support the management of acid-related gastrointestinal conditions associated with impaired gastric motility, as directed by a qualified healthcare professional.
The formulation combines Pantoprazole Sodium 40 mg with Cinitapride 3 mg, providing a dual therapeutic approach for acid control and gastrointestinal motility.
Farzole CT is part of the Farlex Pharmaceuticals Gastro and Anti-Ulcer portfolio, suitable for pharma distributors, PCD pharma franchise partners, stockists and healthcare business partners looking to expand their gastrointestinal product portfolio.
Product Highlights
Pantoprazole + Cinitapride combination
40 mg + 3 mg strength
Capsule dosage form
10 × 10 capsule packing
Designed for gastrointestinal care
Suitable for the Gastro and Anti-Ulcer product segment
Prescription medicine
×
Send Enquiry
ISO, WHO And GMP Certified
(For Pharma Franchise & Third Party)